Dr. Christopher A. Barker, MD, is a board-certified radiation oncologist specializing in the treatment of skin cancer, including melanoma, and eye cancer using radiation therapy. He serves as Vice-Chair for Clinical Research in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center (MSK), where he has been a member of the team since 2006. Dr. Barker sees patients at Memorial Hospital in Manhattan and MSK Westchester. Prior to joining MSK, he was a Howard Hughes Medical Institute Research Scholar in the Radiation Oncology Branch of the National Cancer Institute, where he developed a focused interest in combining cancer medicines with radiation therapy to improve treatment effectiveness. He is one of a small number of radiation oncologists in the country who concentrate specifically on skin and eye cancers, and he works within a dedicated multidisciplinary team to deliver advanced radiation techniques, including superficial radiation therapy, electronic and radioisotope-based brachytherapy, stereotactic radiosurgery, and proton therapy.
Why they are a top doctor
Research papers · PubMed
136
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
15.2k
How often other doctors and researchers build on their work.
Known for
Brachytherapy and proton therapy
The distinction that sets them apart from other radiation oncologists.
Specializes in
External beam radiation and stereotactic radiosurgery (SRS)
A narrow focus means they see far more of these cases than a general oncologist.
Background
Education
Medical school: MD, University of Florida
Residency: Radiation Oncology - Memorial Sloan Kettering Cancer Center
Fellowship: National Cancer Institute · Memorial Sloan Kettering Cancer Center